Craft

Advanced
  • Home
  •  / Aptose Biosciences
Aptose Biosciences

Aptose Biosciences

Stock Price

$0.4

2024-10-29

Market Capitalization

$7.1 M

2024-10-29

Aptose Biosciences Summary

Company Summary

Overview
Aptose Biosciences (also known as Lorus Therapeutics) is a biotechnology company. It discovers and develops personalized treatment strategies for patients with life-threatening hematologic malignancies (cancers of the blood, bone marrow and lymphoid tissues).
Type
Public
Status
Active
Founded
2014
HQ
Toronto, CA | view all locations
Website
https://aptose.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Table of Contents

Key People

  • William G. Rice

    William G. Rice, Chairman of the Board, President & Chief Executive Officer

  • Denis R. Burger

    Denis R. Burger, Director

    • Carol Ashe
    • Rafael Bejar

      Rafael Bejar, Senior Vice President, Chief Medical Officer

    LocationsView all

    3 locations detected

    • Toronto, ON HQ

      Canada

      251 Consumers Rd #1105, North York

    • San Diego, CA

      United States

      12770 High Bluff Dr #120

    • San Diego, CA

      United States

      3550 General Atomics Ct

    Aptose Biosciences Financials

    Summary Financials

    Net income (Q1, 2026)
    ($7.6M)
    Cash (Q1, 2026)
    $1.0M
    Enterprise value
    $6.1M

    Competitors and Similar Companies

    Compare competitors

    Footer menu

    Product

    Solutions

    Resources

    Company

    © Craft.co 2026
    Share price data provided by IEX